Henriksson F, Agardh C D, Berne C, Bolinder J, Jönsson B
Centrum för hälsoekonomi, Handelshögskolan i Stockholm.
Lakartidningen. 1999 Sep 15;96(37):3915-6, 3919.
Cost-of-illness studies have shown diabetes to be associated with substantial direct and indirect costs, accounting for 5-6 percent of total health care expenditure. In a Swedish study, where total costs were divided into costs due to management of diabetes and costs due to complications, the total annual cost to the community was estimated to be SEK 5.7 billion in 1994, costs due to complications being the major item, accounting for over 75 per cent of the total. There have been few other Swedish studies of costs for diabetes or diabetes-related complications. The most widely studied category of complications is diabetes-related foot ulcers, with an estimated annual cost of SEK 1-2 billion. However, earlier studies were marred by shortcomings: costs estimated for the main diagnosis only, without breakdown into categories or distinction between type 1 and type 2 diabetes, sources of data other than official data-bases ignored, etc. Diabetes care in Sweden is of high quality, and substantial clinical, epidemiological and health economics research has been carried out. It is important that Sweden contributes to international research on health economics aspects of diabetes.
疾病成本研究表明，糖尿病与大量直接和间接成本相关，占医疗保健总支出的5%至6%。在一项瑞典研究中，总成本被分为糖尿病管理成本和并发症成本，1994年社区的年度总成本估计为57亿瑞典克朗，并发症成本是主要项目，占总成本的75%以上。瑞典很少有其他关于糖尿病或糖尿病相关并发症成本的研究。研究最广泛的并发症类别是糖尿病相关足溃疡，估计每年成本为10亿至20亿瑞典克朗。然而，早期研究存在缺陷：仅估计主要诊断的成本，未细分为类别，也未区分1型和2型糖尿病，忽略官方数据库以外的数据来源等。瑞典的糖尿病护理质量很高，并且已经开展了大量临床、流行病学和卫生经济学研究。瑞典为糖尿病卫生经济学方面的国际研究做出贡献很重要。
